Michael J Quon Selected Research

Michael J Quon Research Topics

Disease

76	Insulin Resistance 01/2020 - 01/2002
17	Type 2 Diabetes Mellitus (MODY) 07/2017 - 02/2002
13	Inflammation (Inflammations) 12/2017 - 06/2005
13	Metabolic Syndrome (Dysmetabolic Syndrome X) 07/2017 - 06/2005
13	Hypertension (High Blood Pressure) 07/2017 - 01/2004
12	Obesity 12/2017 - 07/2004
12	Atherosclerosis 04/2015 - 01/2004
11	Cardiovascular Diseases (Cardiovascular Disease) 01/2017 - 02/2007
5	Hyperlipidemias (Hyperlipidemia) 03/2011 - 08/2004
5	Coronary Disease (Coronary Heart Disease) 02/2008 - 06/2005
4	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 12/2016 - 02/2009
4	Coronary Artery Disease (Coronary Atherosclerosis) 04/2010 - 12/2005
4	Hyperinsulinism (Hyperinsulinemia) 07/2008 - 01/2002
4	Hyperemia 06/2005 - 12/2004
3	Hypercholesterolemia 07/2017 - 02/2011
3	Hyperglycemia 07/2015 - 02/2007
3	Metabolic Diseases (Metabolic Disease) 09/2013 - 03/2011
3	Hypertriglyceridemia 02/2012 - 06/2005
3	Heart Diseases (Heart Disease) 04/2010 - 12/2005
3	Dyslipidemias (Dyslipidemia) 02/2008 - 02/2007
2	Infections 12/2017 - 12/2002
2	Glucose Intolerance 01/2016 - 07/2015
2	Infarction (Infarctions) 09/2009 - 05/2007
2	Essential Hypertension 12/2008 - 01/2008
2	Thrombosis (Thrombus) 09/2007 - 11/2005
2	Neoplasms (Cancer) 02/2003 - 11/2002
1	Sepsis (Septicemia) 01/2018
1	Acute Coronary Syndrome 01/2018
1	Ischemic Stroke 01/2018
1	Atrial Fibrillation 01/2018
1	Hemorrhage 01/2018
1	Ventricular Remodeling 12/2015

Drug/Important Bio-Agent (IBA)

45	Insulin (Novolin)FDA Link 01/2020 - 01/2002
29	AdiponectinIBA 12/2016 - 12/2004
21	Glucose (Dextrose)FDA LinkGeneric 01/2017 - 02/2002
11	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 07/2017 - 05/2005
7	Nitric Oxide (Nitrogen Monoxide)FDA Link 12/2016 - 11/2005
6	Simvastatin (Zocor)FDA LinkGeneric 07/2012 - 06/2005
6	Proteins (Proteins, Gene)FDA Link 07/2012 - 11/2002
5	LDL CholesterolIBA 03/2014 - 01/2008
5	Fenofibrate (CiL)FDA LinkGeneric 02/2012 - 05/2005
5	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 10/2009 - 06/2005
4	TeaIBA 01/2017 - 05/2007
4	Insulin ReceptorIBA 12/2015 - 04/2004
4	Vasodilator Agents (Vasodilators)IBA 10/2013 - 08/2005
4	Pravastatin (Pravachol)FDA LinkGeneric 10/2013 - 06/2009
4	Pharmaceutical PreparationsIBA 10/2013 - 09/2007
4	PolyphenolsIBA 09/2013 - 05/2007
4	LipidsIBA 07/2012 - 01/2004
4	AdipokinesIBA 02/2011 - 06/2007
4	candesartanIBA 04/2010 - 02/2006
4	Ramipril (Altace)FDA LinkGeneric 04/2010 - 06/2005
4	C-Reactive ProteinIBA 06/2009 - 05/2005
3	CholesterolIBA 07/2017 - 01/2004
3	Lipoproteins (Lipoprotein)IBA 06/2013 - 02/2008
3	LeptinIBA 07/2012 - 06/2008
3	Messenger RNA (mRNA)IBA 03/2011 - 11/2002
3	Atorvastatin (Lipitor)FDA Link 02/2011 - 05/2005
3	ApolipoproteinsIBA 03/2010 - 02/2008
3	Nonesterified Fatty Acids (NEFA)IBA 03/2009 - 08/2004
3	Angiotensin IIIBA 03/2009 - 03/2006
3	Fibric Acids (Fibrates)IBA 02/2008 - 05/2005
3	Phosphatidylinositols (Phosphatidylinositol)IBA 08/2007 - 12/2002
3	Cardiovascular AgentsIBA 02/2007 - 12/2005
3	Endothelin-1 (Endothelin 1)IBA 12/2006 - 04/2006
3	Insulin Receptor Substrate ProteinsIBA 06/2005 - 12/2002
3	Phosphotransferases (Kinase)IBA 06/2005 - 07/2003
3	Serine (L-Serine)FDA Link 08/2004 - 12/2002
2	Fatty Acids (Saturated Fatty Acids)IBA 12/2017 - 05/2013
2	Toll-Like Receptors (Toll-Like Receptor)IBA 01/2017 - 05/2013
2	Interleukin-1 Receptor-Associated KinasesIBA 01/2017 - 06/2005
2	Infliximab (Remicade)FDA Link 12/2016 - 07/2008
2	CaspasesIBA 11/2015 - 07/2015
2	Exenatide (Byetta)FDA Link 10/2014 - 01/2014
2	Rosuvastatin Calcium (Crestor)FDA Link 06/2013 - 07/2012
2	Hydroxymethylglutaryl CoA Reductases (HMG CoA Reductase)IBA 06/2013 - 03/2011
2	Rosiglitazone (Avandia)FDA Link 09/2009 - 12/2006
2	IGF Type 1 Receptor (IGF 1 Receptor)IBA 07/2009 - 08/2006
2	CytokinesIBA 03/2009 - 07/2008
2	Nitroprusside (Sodium Nitroprusside)FDA LinkGeneric 07/2008 - 01/2006
2	Ascorbic Acid (Vitamin C)FDA LinkGeneric 07/2008 - 01/2006
2	PPAR alphaIBA 02/2008 - 11/2005
2	Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA 07/2007 - 01/2002
2	Enalapril FDA LinkGeneric 05/2007 - 12/2006
2	CD40 Ligand (CD40L)IBA 03/2007 - 01/2007
2	Nitroglycerin (Dynamite)FDA LinkGeneric 03/2007 - 01/2004
2	Vasoconstrictor AgentsIBA 12/2006 - 08/2005
2	2,4-thiazolidinedione (thiazolidinedione)IBA 07/2006 - 08/2003
2	PPAR gammaIBA 07/2006 - 08/2003
2	Fibrinogen (Factor I)FDA Link 06/2005 - 05/2005
2	Malondialdehyde (Propanedial)IBA 06/2005 - 12/2004
1	AnticoagulantsIBA 01/2018
1	Pathogen-Associated Molecular Pattern MoleculesIBA 12/2017
1	Toll-Like Receptor 4IBA 12/2017
1	Interleukin-1 Receptors (Interleukin 1 Receptor)IBA 01/2017
1	Estrogens (Estrogen)FDA Link 01/2016
1	Estradiol (Delestrogen)FDA LinkGeneric 01/2016
1	Letrozole (Femara)FDA LinkGeneric 01/2016

Therapy/Procedure

31	Therapeutics 07/2017 - 12/2004
2	Microbubbles 12/2008 - 11/2006